Olfactory Dysfunction is Associated with Mild Cognitive Impairment (MCI)
This article is written based on the presentation done by Prof Wang De Yun at the NUS Psychiatry Symposium on Ageing-in-Place held on 27 Apr 2023.
Olfactory impairment, or more commonly referred to as sense of smell, is ageing related. The ability to detect and identify smell has also long been linked with cognitive decline in older adults. However, there remains questions on its association with mild cognitive impairment (MCI) and by extension, dementia.As part of the Yeo
Boon Khim Mind Science Centre’s Community Health and
Intergenerational (CHI) Study, Prof Wang De Yun from NUS Department of
Otolaryngology, conducted a study to assess the olfactory function of
community-dwelling older adults in Singapore and its link with their cognitive
function. For this study, researchers at NUS developed a localised version of
the nine-item smell test to better screen the population.
Read more below!
Smell ability as a predictive tool for
Cognitive Impairment
When it comes to
modifiable risks of dementia, the focus is often on vision and hearing
impairments rather than smell impairment. Nonetheless, there are studies
indicating a potential link between smell identification ability and MCI.A meta-analysis found
that smell identification is impaired in those with MCI compared with healthy
older adults. Longitudinal studies also showed that cognitively healthy
individuals with smell impairments at baseline subsequently developed MCI in
the follow-up.
The evidence suggests
that smell identification has the potential to detect and predict the risks of
developing dementia in later life.
To the best of our
knowledge, there has yet to be any study examining smell function in
Singapore’s healthy and/or cognitively impaired community-dwelling older adult
population. Mind Science Centre’s study aimed to assess their smell
identification ability and associate the outcomes with their cognitive status.
Culture specific smell test developed in NUS
The
original nine-item smell test developed by the University of Pennsylvania
(UPSIT) included items as liquorice, dill pickle, and skunk. These are not
common in Singapore and participants often struggle to recognise and identify
them.To better
screen and evaluate smell function in Singapore’s older adult population, our
researchers recognised a need to create a localised version of the smell test
that is culture-specific to our population. Researchers in NUS developed the
Singapore version of the 9-items Smell Test Panel based on a local smell
familiarity survey. This includes almond, banana, cinnamon, coconut, lemon,
orange, pineapple, rose, and mushroom.
Beyond
this study, other clinicians and researchers could also benefit from this
locally developed smell test to better screen their patients or research
participants.
Participants aged 60
years and above were recruited from a larger epidemiological study titled
Community Health and Intergenerational (CHI) study. The smell test and
neuropsychological testing are part of a 10-hour assessment done over five
separate visits. More details on that can be found in the CHI
study protocol.
Smell
Tests For Cognitive Impairment
The locally developed
nine-item smell test was used to assess smell detection and identification. The
test was conducted in an interview format with each odour sample (in total 9)
given only once. Between each odour, there was at least a 30-second time
interval to prevent sensory fatigue.
For the smell detection task,
participants were asked to respond yes or no based on their perception of the
presence of an odour. Each successful detection was scored a point.
For the smell identification task,
participants were asked to identify the same test odour before choosing through
4 narrated answer choices. If they thought none of the answer choices matched
the test odour, they were allowed to describe the odour instead. Each
successful identification was scored a point.
Cognitive
Function Tests - Testing for Cognitive Impairment
Participants’
cognition was measured with the modified mini-mental state examination (MMSE)
scale, clinical dementia rating (CDR) scale, and a validated battery of neurocognitive
tests. The protocol is described in more details here.
Diagnosis of the
participants’ cognitive status was made at consensus review meetings involving
two psychiatrists and a neuropsychologist. Participants were categorised into
normal active
ageing, MCI, or dementia and further
subtyped as amnestic or non-amnestic, and single or multiple domain.
- NA (normal
ageing)
- naMCI_SD
(non-amnestic mild cognitive impairment, single domain)
- naMCI_MD
(non-amnestic mild cognitive impairment, multiple domains)
- aMCI_SD
(amnestic mild cognitive impairment, single domain)
- aMCI_MD
(amnestic mild cognitive impairment, multiple domains)
- Dementia




Comments
Post a Comment